SCHEMBL10149458

SCHEMBL10149458

CC[C@H]1OC(C(C#N)=CO)[C@@H]2OC(C)(C)O[C@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183868 0.88 PI4KA (0.32) —
SCHEMBL18026288 0.85 — —
SCHEMBL18026286 0.81 — —
SCHEMBL10149461 0.78 — —
SCHEMBL14551315 0.73 CA2 (0.30) —
SCHEMBL866263 0.72 ALDH1A1 (0.36) —
SCHEMBL10183344 0.71 — —
SCHEMBL10183340 0.71 — —
SCHEMBL17175093 0.71 — —
SCHEMBL10184229 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160244475-A1 SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2016-08-25 — — US disclosed
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES WANG ZHONG (US) 2012-03-29 — — US disclosed
Send feedback